Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
News|Articles|January 2, 2018

Risk Assessments and Sourcing Strategies for Excipients and APIs

Author(s)USP
Advertisement
External Link - PT1217 USP-Andruski F&C pr1f2-Web.pdf

Advertisement
PharmTech News

Related Content

Advertisement

PharmTech Weekly Roundup—June 26, 2026

BySusan Haigney
June 29th 2026
Human Accountability with AI in GMP

PharmTech Explained: Human Accountability with AI in GMP

ByZachary Zubulake
June 29th 2026
Sebastián Arana

MilliporeSigma's Arana Maps the Gaps Holding Back CGT Manufacturing

BySebastián Arana,Feliza Mirasol
June 26th 2026

Drug Digest: How Advanced Analytics Partnerships Enhance the Biopharma Value Chain

ByFeliza Mirasol,Emily Schoenthaler,Matt Truppo,Richard Jaenisch,Brian Drapeau
June 26th 2026
Anil Kane

Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value

ByAnil Kane,Nicholas Jacobus,Feliza Mirasol
June 26th 2026
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Don’t Make AI Smarter. Make It Traceable.

2

Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value

3

FDA Updates Master Protocol: What Developers Need to Know

4

MilliporeSigma's Arana Maps the Gaps Holding Back CGT Manufacturing

5

FDA Approves Pfizer’s Breast Cancer Treatment

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us